Skip to main content
. 2018 Oct 30;9:2603. doi: 10.3389/fmicb.2018.02603

FIGURE 2.

FIGURE 2

The potential effect of immune mediators on the development of lung damage at different stages of disease. G-CSF, granulocyte-colony stimulating factor; IL, interleukin; LTB4, leukotriene B4; LXA4, lipoxin A4; mφ, macrophage; neutro, neutrophils; NO, nitric oxide; PGE2, prostaglandin E2; TNF, tumor necrosis factor.